The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-5085
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue ; volume:7 ; number:1 ; day:24 ; month:11 ; year:2016 ; pages:1-16 ; date:12.2016
The EPMA journal / European Association for Predictive, Preventive and Personalised Medicine ; 7, Heft 1 (24.11.2016), 1-16, 12.2016
- Urheber
-
Veauthier, Christian
- Beteiligte Personen und Organisationen
-
Hasselmann, Helge
Gold, Stefan M.
Paul, Friedemann
SpringerLink (Online service)
- DOI
-
10.1186/s13167-016-0073-3
- URN
-
urn:nbn:de:1111-201612127682
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Veauthier, Christian
- Hasselmann, Helge
- Gold, Stefan M.
- Paul, Friedemann
- SpringerLink (Online service)
Ähnliche Objekte (12)
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy
COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials